NeuroSense Therapeutics Ltd. Adjustments For Reconcile Profit Loss
NeuroSense Therapeutics Ltd. (NRSN) reported Adjustments For Reconcile Profit Loss of $242.00 thousand for the 6-month period ending 2022-06-30, per its 6-K/A filed 2023-01-19.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForReconcileProfitLoss · last filed 2023-01-19
- 2022-06-30: Adjustments For Reconcile Profit Loss 6 month $242.00K.
| Period end | Adjustments For Reconcile Profit Loss 6 month |
|---|---|
| 2022-06-30 | $242.00K 6-K/A · filed 2023-01-19 |